Wednesday 23 September 2020
Investorideas.com - Cannabis Stock News: Spyder Cannabis (TSXV: SPDR) Announces Opening of Calgary Cannabis Dispensary
Investorideas.com - Cannabis Stock News: Spyder Cannabis (TSXV: SPDR) Announces Opening of Calgary Cannabis Dispensary
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 471 - Interview with Tim Moore and Susan Chappelle, Co-CEO’s of Havn Life Sciences (CSE: $HAVN.C)
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 471 - Interview with Tim Moore and Susan Chappelle, Co-CEO’s of Havn Life Sciences (CSE: $HAVN.C)
Today’s
podcast sponsored by Cannabis Suisse Corp. (OTC: $CSUI), a fully licensed
cannabis cultivation and distribution company in Switzerland
Delta, Kelowna, BC, September 23, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/092320-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/09231Interview-HAVN.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
Today’s podcast is
sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully
licensed cannabis cultivation and distribution company in Switzerland, for
recreational tobacco products and medical CBD oils. The Company's facilities
for producing cannabis are based in Dietikon, Switzerland, and contain the art
surveillance equipment to enable an around the clock webcast. Cannabis Suisse
grows high quality, organic cannabis with sustainable, all-natural principles.
The Company's products are laboratory tested to ensure the end users have
access to a standardized, safe and consistent product. Cannabis Suisse
proprietary trademarked MoldStandard is a quantitative microbiology method for
analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse
proprietary trademarked CannaMec is a method for quantifying and removing
residual solvents during packaging and storage of CBD products. Cannabis Suisse
Corp. currently sells via a distribution network of Swiss retailers and online
shops, under the retail brand Alpine Cannabis.
In
today’s podcast Investorideas interview Tim Moore and Susan Chappelle, the
Co-CEO’s of Havn Life Sciences Inc. (CSE :
HAVN), a biotechnology company focused on unlocking human
potential using evidence-informed research, and developing standardized
psychoactive compounds derived from plants and fungi. We discuss the company’s
most recent
announcement that, on August 31, 2020, its wholly-owned
subsidiary, HAVN Research Inc., was granted a Section 56 exemption by Health
Canada, pursuant to which it now has the ability to possess certain amounts of
pure psilocybin for scientific purposes, specifically for the research and
development of quality control methods.
Havn Life intends to immediately
begin work on experiments with the objective of developing a set of methods for
the safe, standardized, quality-controlled production of medical compounds
extracted from the Psilocybe spp. mushroom.
"We are thrilled to be among
the first to receive permission from the Canadian government to begin work with
psilocybin", stated Tim Moore, Co-CEO of Havn Life. "This important
milestone will enable Havn to begin working toward creating method-validation
and analytical chemistry to standardize methods for quality control and testing
of these substances."
"Having access to compounds is
essential in order to further research in the medical field. This is the start
of our journey into developing standardized protocols to ensure that as this
industry grows, we understand efficient new methodology", stated Susan
Chapelle, Havn Life Co-CEO, noting the advent of new technology and variables
in extraction have changed significantly in the last decade.
Moore and Chappelle went on to
discuss the company’s two pronged approach to the psychedelic market as well as
what separates them from other competitors entering this new landscape.
“Haven Life is an exciting
opportunity in that we are focusing on the supply chain. Basically there have
been very few companies focusing on supply chain. Most of the research going on
right now is with synthetics, but the people using these compounds use them in
their natural forms. Creating a natural compound library so researchers can
extract the compounds they need to make sure that the human performance and
outcomes are stable and repeatable is such an important space to be in. Our team
also has strong retail, scientific and policy experience makes us well attuned
to the regulatory space as well. We’ve placed ourselves in the supply chain as
opposed to the end user clinic space because we think this a much better
opportunity to ensure safe, standardized and effective compounds,” commented
Susan Chappelle.
Chappelle also went on to discuss
how this industry aims to deal with the very unique and subjective effects and
experience of psilocybin saying, “If you’re picking a mushroom from the woods,
you have no idea how much psilocybin is in that mushrooms. Having the
researchers have safe standardized compounds and dosing of the effective
ingredients and then be in a clinic, a safe environment, I think the landscape
over the next few years is going to rapidly change.”
Tim and Susan went on to discuss in
more detail the importance of creating a standardized supply chain, the
importance of working with natural whole plant compounds versus synthetic
compounds as well as the future of psilocybin research.
To find out more about Havn Life
Sciences visit their website here.
Once again, today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. Disclosure: Cannabis
Suisse Corp. (OTC: CSUI ),is
a paid featured company on Investorideas.com More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
#CBD and #Hemp #stocks to watch (OTC: $CSUI) (OTC: $MJNA) (CSE: $TGIF.C) (OTCQX: $TGIFF), (TSXV: $KHRN.V) (OTCQX: $KHRNF) as Distribution Platforms Grow Market
#CBD and #Hemp #stocks to watch (OTC: $CSUI) (OTC: $MJNA) (CSE: $TGIF.C)
(OTCQX: $TGIFF), (TSXV: $KHRN.V) (OTCQX: $KHRNF) as Distribution Platforms Grow
Market
Point
Roberts WA, Delta, BC –September 23, 2020 - Investorideas.com, a leading
investor news resource covering hemp and cannabis stocks releases a special
report on the continued growth of the global CBD/hemp industry as additional
international markets come into play and how smart companies hedging for the
future are putting their focus into globalized distribution systems.
Read this article, featuring CSUI in full at https://www.investorideas.com/news/2020/cannabis/09231CBD-HEMP-Distribution-Platforms.asp
As
we see more global acceptance of the hemp/CBD industry, whether in the form of
new import/export regulations coming into play in South America, potential
markets opening up South East Asia, Japan and South Korea or larger companies
like Amazon being more acceptant of hemp/CBD products, the CBD industry is
going global faster than many anticipated, especially in the midst of a global
pandemic. That being said, one of the most significant drivers of this industry
today is the renewed focus on health and wellness and immune boosting products
that we’ve seen ramp up due to the COVID-19 pandemic.
One company based out of Switzerland, Cannabis Suisse Corp. (OTC: CSUI), a fully-licensed Swiss cannabis
cultivation and distribution company for recreational tobacco products and
medical CBD oils, recently announced its own online expansion plans including
the upcoming launch of a new brand on Amazon.
Сannabis Suisse Corp. is developing its
own line of products including hemp oil, hemp protein, hemp gummies and hemp
hearts with all the appropriate certificates and licenses, for sale on Amazon.
This news follows a recent
announcement
for online distribution of its cannabis and CBD products with uWeed from their
retail outlets and online store (www.uweed.ch).
The expansion into online sales of hemp
gives the company, which is headquartered in Switzerland, wider access and
inroads into US markets as the legal environment for CBD products evolves.
Mr.
Alain Parrik, COO & Director said, “Amazon is an important distribution
outlet for us as we ramp up for expansion across multiple online retail
platforms. Introducing a new line of hemp products paves the wave for
additional products in the future.”
Cannabis
Suisse Corp. will be in compliance with Amazon rules and respects their
position that CBD is currently banned on Amazon but hemp products are not.
The Company, as a registered manufacturer
of both products will continue to use flowers with the highest concentration of
CBD. For the new Amazon product line, oil will be squeezed from the seeds
allowing Cannabis Suisse to use the whole plant in its production and benefit
from it.
The Company grows high quality, organic
cannabis with sustainable, all-natural principles. Cannabis Suisse products are
laboratory tested to ensure the end users have access to a standardized, safe
and consistent product.
Source:
Brightfield Group Quarterly CBD Consumer Survey, Q2, 2020, Sample size = 5,000
Looking more to domestic markets, 1933 Industries Inc. (CSE:
TGIF)
(OTCQX:
TGIFF),
a vertically-integrated cannabis consumer packaged goods company with a diverse
portfolio of consumer-driven brands, recently announced that it has set up
distribution of its Canna Hemp™ line of wellness products in conjunction with
CBD Plus, the largest and most trusted supplier of CBD products across the
United States.
The Company reports that its wholly-owned
subsidiary, Infused MFG, signed a Master Services and Supply Agreement with MCV
Enterprises LLC, an Oklahoma company doing business as CBD Plus and CBD Plus
USA, for the marketing and sale of Canna Hemp™ products in CBD Plus
corporate-owned and franchisee brick and mortar retail stores. The one-year
Agreement includes a 45-day trial period, effective immediately.
CBD Plus is focused in the Midwest and
Southern US, with over 120 locations and growing - in Texas, Oklahoma, Kansas,
Arkansas, Tennessee, Georgia, Florida, North Carolina, and Maryland. The
partnership with CBD Plus is another important step for the Company as it
builds the Canna Hemp™ line as a leading brand in the US CBD market. According
to the latest outlook by the Brightfield Group, hemp-based CBD US sales will
reach $12.4 billion by 2023 and $16.8 billion by 2025.
Mr. Eugene Ruiz, President of 1933
Industries said, "CBD Plus is a well-respected source of safe, legal and affordable
CBD products that meet the highest standards in the industry. We are pleased
that our Canna Hemp™ line meets and exceeds those high standards. We look
forward to collaborating with CBD Plus to increase awareness and education
regarding the benefits and value of CBD in our everyday lives."
"CBD Plus and its family of
franchisees is proud to announce its relationship with 1933 industries",
said Mr. Charles V. Reynolds III, CEO of CBD Plus. "We look forward to
introducing Canna Hemp™ products to our entire customer base nationwide.
Quality Assurance and Cannabis Education have always been cornerstones of the
CBD Plus USA mission, and we are excited to partner with a brand such as Canna
Hemp™ that shares those values. We remain committed to helping educate the
public on all of the benefits and uses of quality CBD, and we believe this
relationship aligns with our goals."
CBD Plus has been committed to improving
the lives of communities since 2017, and has now grown into a trusted source of
CBD products in the US. Founded on the cornerstone of empowering customers to
live their best lives, CBD Plus has become an authoritative advocate for CBD,
and a dedicated educator of the benefits of CBD oil. CBD Plus offers a variety
of self-care and lifestyle products with CBD that exceeds the industry standard
of quality, producing carefully extracted, pesticide-free, and non-GMO
products.
Looking back to the international market, Medical Marijuana, Inc. (OTC:
MJNA),
the first-ever publicly traded cannabis company in the United States that
launched the world’s first-ever cannabis-derived nutraceutical products, brands
and supply chain, recently
announced
that its subsidiary HempMeds® Brasil had its best revenue month ever in Company
history in August 2020.
“Since 2015, HempMeds® Brasil has sold more
than 80,000 units of cannabidiol (CBD) to Brazilian citizens,” said Medical
Marijuana, Inc. CEO, Dr. Stuart Titus. “We are proud to be the recipients of
the first permits to import CBD into Brazil and we have been able to become
industry leaders there.”
“Our Company was formed and is led by
Brazilians – we care immensely about providing people here with affordable,
high-quality CBD products that are legal and scientifically-proven,” said
HempMeds® Co-CEO, Caroline Heinz. “We have showcased to citizens even despite a
global pandemic and a very poor currency exchange rate, we have been able to
increase our sales and make our products affordable for the struggling economy
through adjusting our prices and offering payment plans.”
Before becoming Co-CEO of HempMeds®’
operations, Heinz served as Vice President of HempMeds® Brasil. She joined the
Company in 2014 and helped pass legislation to get the Brazilian government to
subsidize CBD for several indications. She was also able to establish two
HempMeds® Brasil offices and create a network of Brazilian doctors and medical
professionals.
Khiron
Life Sciences Corp.
(TSXV:
KHRN)
(OTCQX:
KHRNF),
a vertically integrated cannabis leader with core operations in Latin America
and Europe, recently
announced
that it has entered into an exclusive distribution agreement with Rappi SAS,
the leading Latin American last-mile multi-vertical platform that is backed
with a USD 1 billion investment from Softbank Group Corp., and Softbank Vision
Fund. The expansive agreement comprises
a 6-month exclusive distribution partnership between Rappi and Khiron to
introduce and distribute the Company's CPG product portfolio across Latin
America through the Rappi platform, starting with KuidaTM, the Company's
branded CBD skincare product line, with the potential to build on the
partnership over time.
Beyond a standard vendor agreement, this
expanded partnership introduces the Company's CBD-based Wellbeing products to
millions of Rappi users across Latin America through its sophisticated
technology and advanced customer-centric marketing strategies. With the Kuida
store already launched on Rappi in May 2020 for the Colombian market,
distribution will be expanded to Uruguay and Costa Rica, where Kuida has been
recently approved. The Company also intends to introduce its product line
through Rappi's fast growing consumer base to countries such as Brazil, Mexico,
Ecuador and Chile, subject to regulatory approvals.
Colombia's Rappi is the market leading
multi-vertical application in Latin America with a presence in Brazil,
Colombia, Mexico, Argentina, Chile, Ecuador, Costa Rica, Uruguay and Peru.
Through its platform, customers buy
products and services and receive home delivery across multiple categories,
including, medical, health, grocery, restaurants, pharmacies, beverage and
professional services among others. In addition, the application has a virtual
wallet, RappiPayTM, where users can make P2P transfers and payments. Rappi has an average of more than 10 million
active users monthly, according to research firm Apptopia, providing deliveries
for almost 100,000 businesses in LatAm, including over 13 million deliveries in
Colombia alone.
"Rappi is the delivery brand that
everyone in Latin America knows and uses daily. The partnership with Rappi
reduces our product launch and logistics costs and transforms our availability
and exposure to millions of customers across the region. Rappi is the last-mile
delivery brand that will help us bring Khiron product to more customers than
ever before. We are proud to establish this first-of-its-kind partnership
between these two companies, which are both industry leaders in LatAm, and were
both founded by Colombians," comments Alvaro Torres, Khiron CEO and
director.
"As the market for consumer cannabis
products and services globalizes it is a natural fit for us to partner with
Khiron to meet our app users´ needs. Like us, they are a recognized leader in
the region, and an innovator in bringing quality products to market,
"comments Simon Borrero, Rappi SAS CEO.
As the CBD/hemp space continues to gain
global momentum, new distribution platforms and models as well as a heavy focus
on product quality, consistency and efficacy will become more and more
paramount for companies looking to be a global player and make no mistake, this
is a global play. With companies like Amazon now also entering into the space,
the level of competition has risen dramatically and investors should now be
looking at the distribution and supply chain of any CBD/hemp company first and
foremost as this looks to be an impactful factor moving forward.
About
Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. Disclosure:
this news article featuring CSUI is a paid for news release on Investorideas.com
– third party (two thousand) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp
Learn more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Follow
us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile
App
for iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact
Investorideas.com
800-665-0411
Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories
Buy a cannabis guest post on Investorideas.com
Tuesday 22 September 2020
Global #CBD/#Hemp Industry Snapshot (OTC: $CSUI) (OTC: $MJNA) (CSE: $TGIF.C) (OTCQX: $TGIFF), (TSXV: $KHRN.V) (OTCQX: $KHRNF)
Global #CBD/#Hemp Industry Snapshot (OTC: $CSUI) (OTC: $MJNA) (CSE: $TGIF.C) (OTCQX: $TGIFF), (TSXV: $KHRN.V) (OTCQX: $KHRNF); @SuisseCorp @1933Industries @MJNA_INC @KhironLife
How Distribution
Platforms Are Growing the Sector
Point
Roberts WA, Delta, BC –September 22, 2020 - Investorideas.com, a
leading investor news resource covering hemp and cannabis stocks releases a
special report on the continued growth of the global CBD/hemp industry as additional
international markets come into play and how smart companies hedging for the
future are putting their focus into globalized distribution systems.
Read this article,
featuring CSUI in full at https://www.investorideas.com/news/2020/cannabis/09221CSUI-MJNA-TGIF-KHRN.asp
As
we see more global acceptance of the hemp/CBD industry, whether in the form of
new import/export regulations coming into play in South America, potential
markets opening up South East Asia, Japan and South Korea or larger companies
like Amazon being more acceptant of hemp/CBD products, the CBD industry is
going global faster than many anticipated, especially in the midst of a global
pandemic. That being said, one of the most significant drivers of this industry
today is the renewed focus on health and wellness and immune boosting products that
we’ve seen ramp up due to the COVID-19 pandemic.
One company based out of Switzerland, Cannabis Suisse Corp. (OTC: CSUI), a fully-licensed Swiss cannabis cultivation and distribution company for recreational tobacco products and medical CBD oils, recently announced its own online expansion plans including the upcoming launch of a new brand on Amazon.
Сannabis Suisse Corp. is
developing its own line of products including hemp oil, hemp protein, hemp
gummies and hemp hearts with all the appropriate certificates and licenses, for
sale on Amazon.
This news follows a recent
announcement for online distribution of its cannabis
and CBD products with uWeed from their retail outlets and online store
(www.uweed.ch).
The expansion into
online sales of hemp gives the company, which is headquartered in Switzerland,
wider access and inroads into US markets as the legal environment for CBD
products evolves.
Mr.
Alain Parrik, COO & Director said, “Amazon is an important distribution
outlet for us as we ramp up for expansion across multiple online retail
platforms. Introducing a new line of hemp products paves the wave for
additional products in the future.”
Cannabis
Suisse Corp. will be in compliance with Amazon rules and respects their
position that CBD is currently banned on Amazon but hemp products are not.
The Company, as a registered
manufacturer of both products will continue to use flowers with the highest
concentration of CBD. For the new Amazon product line, oil will be squeezed
from the seeds allowing Cannabis Suisse to use the whole plant in its
production and benefit from it.
The Company grows high quality,
organic cannabis with sustainable, all-natural principles. Cannabis Suisse
products are laboratory tested to ensure the end users have access to a
standardized, safe and consistent product.
Source: Brightfield
Group Quarterly CBD Consumer Survey, Q2, 2020, Sample size = 5,000
Looking
more to domestic markets, 1933
Industries Inc. (CSE:
TGIF) (OTCQX:
TGIFF), a vertically-integrated cannabis consumer packaged
goods company with a diverse portfolio of consumer-driven brands, recently announced that it
has set up distribution of its Canna Hemp™ line of wellness products in
conjunction with CBD Plus, the largest and most trusted supplier of CBD
products across the United States.
The
Company reports that its wholly-owned subsidiary, Infused MFG, signed a Master
Services and Supply Agreement with MCV Enterprises LLC, an Oklahoma company
doing business as CBD Plus and CBD Plus USA, for the marketing and sale of
Canna Hemp™ products in CBD Plus corporate-owned and franchisee brick and
mortar retail stores. The one-year Agreement includes a 45-day trial period,
effective immediately.
CBD Plus
is focused in the Midwest and Southern US, with over 120 locations and growing -
in Texas, Oklahoma, Kansas, Arkansas, Tennessee, Georgia, Florida, North
Carolina, and Maryland. The partnership with CBD Plus is another important step
for the Company as it builds the Canna Hemp™ line as a leading brand in the US
CBD market. According to the latest outlook by the Brightfield Group,
hemp-based CBD US sales will reach $12.4 billion by 2023 and $16.8 billion by
2025.
Mr.
Eugene Ruiz, President of 1933 Industries said, "CBD Plus is a
well-respected source of safe, legal and affordable CBD products that meet the
highest standards in the industry. We are pleased that our Canna Hemp™ line
meets and exceeds those high standards. We look forward to collaborating with
CBD Plus to increase awareness and education regarding the benefits and value
of CBD in our everyday lives."
"CBD
Plus and its family of franchisees is proud to announce its relationship with
1933 industries", said Mr. Charles V. Reynolds III, CEO of CBD Plus.
"We look forward to introducing Canna Hemp™ products to our entire
customer base nationwide. Quality Assurance and Cannabis Education have always
been cornerstones of the CBD Plus USA mission, and we are excited to partner
with a brand such as Canna Hemp™ that shares those values. We remain committed
to helping educate the public on all of the benefits and uses of quality CBD,
and we believe this relationship aligns with our goals."
CBD Plus
has been committed to improving the lives of communities since 2017, and has
now grown into a trusted source of CBD products in the US. Founded on the
cornerstone of empowering customers to live their best lives, CBD Plus has
become an authoritative advocate for CBD, and a dedicated educator of the
benefits of CBD oil. CBD Plus offers a variety of self-care and lifestyle
products with CBD that exceeds the industry standard of quality, producing
carefully extracted, pesticide-free, and non-GMO products.
Looking
back to the international market, Medical
Marijuana, Inc. (OTC:
MJNA), the first-ever publicly traded cannabis company in
the United States that launched the world’s first-ever cannabis-derived
nutraceutical products, brands and supply chain, recently
announced that its subsidiary HempMeds® Brasil had its best
revenue month ever in Company history in August 2020.
“Since
2015, HempMeds® Brasil has sold more than 80,000 units of cannabidiol (CBD) to
Brazilian citizens,” said Medical Marijuana, Inc. CEO, Dr. Stuart Titus. “We
are proud to be the recipients of the first permits to import CBD into Brazil
and we have been able to become industry leaders there.”
“Our
Company was formed and is led by Brazilians – we care immensely about providing
people here with affordable, high-quality CBD products that are legal and
scientifically-proven,” said HempMeds® Co-CEO, Caroline Heinz. “We have
showcased to citizens even despite a global pandemic and a very poor currency
exchange rate, we have been able to increase our sales and make our products
affordable for the struggling economy through adjusting our prices and offering
payment plans.”
Before
becoming Co-CEO of HempMeds®’ operations, Heinz served as Vice President of
HempMeds® Brasil. She joined the Company in 2014 and helped pass legislation to
get the Brazilian government to subsidize CBD for several indications. She was
also able to establish two HempMeds® Brasil offices and create a network of
Brazilian doctors and medical professionals.
Khiron Life Sciences Corp. (TSXV:
KHRN) (OTCQX:
KHRNF), a vertically integrated cannabis leader with core
operations in Latin America and Europe, recently
announced that it has entered into an exclusive distribution
agreement with Rappi SAS, the leading Latin American last-mile multi-vertical
platform that is backed with a USD 1 billion investment from Softbank Group
Corp., and Softbank Vision Fund. The
expansive agreement comprises a 6-month exclusive distribution partnership
between Rappi and Khiron to introduce and distribute the Company's CPG product
portfolio across Latin America through the Rappi platform, starting with
KuidaTM, the Company's branded CBD skincare product line, with the potential to
build on the partnership over time.
Beyond a
standard vendor agreement, this expanded partnership introduces the Company's
CBD-based Wellbeing products to millions of Rappi users across Latin America
through its sophisticated technology and advanced customer-centric marketing
strategies. With the Kuida store already launched on Rappi in May 2020 for the
Colombian market, distribution will be expanded to Uruguay and Costa Rica,
where Kuida has been recently approved. The Company also intends to introduce
its product line through Rappi's fast growing consumer base to countries such
as Brazil, Mexico, Ecuador and Chile, subject to regulatory approvals.
Colombia's
Rappi is the market leading multi-vertical application in Latin America with a
presence in Brazil, Colombia, Mexico, Argentina, Chile, Ecuador, Costa Rica,
Uruguay and Peru.
Through
its platform, customers buy products and services and receive home delivery
across multiple categories, including, medical, health, grocery, restaurants,
pharmacies, beverage and professional services among others. In addition, the
application has a virtual wallet, RappiPayTM, where users can make P2P
transfers and payments. Rappi has an
average of more than 10 million active users monthly, according to research
firm Apptopia, providing deliveries for almost 100,000 businesses in LatAm,
including over 13 million deliveries in Colombia alone.
"Rappi
is the delivery brand that everyone in Latin America knows and uses daily. The partnership
with Rappi reduces our product launch and logistics costs and transforms our
availability and exposure to millions of customers across the region. Rappi is
the last-mile delivery brand that will help us bring Khiron product to more
customers than ever before. We are proud to establish this first-of-its-kind
partnership between these two companies, which are both industry leaders in
LatAm, and were both founded by Colombians," comments Alvaro Torres,
Khiron CEO and director.
"As
the market for consumer cannabis products and services globalizes it is a
natural fit for us to partner with Khiron to meet our app users´ needs. Like
us, they are a recognized leader in the region, and an innovator in bringing
quality products to market, "comments Simon Borrero, Rappi SAS CEO.
As the
CBD/hemp space continues to gain global momentum, new distribution platforms
and models as well as a heavy focus on product quality, consistency and
efficacy will become more and more paramount for companies looking to be a global
player and make no mistake, this is a global play. With companies like Amazon
now also entering into the space, the level of competition has risen
dramatically and investors should now be looking at the distribution and supply
chain of any CBD/hemp company first and foremost as this looks to be an
impactful factor moving forward.
About
Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third
party news, research and original financial content. Learn about investing in
stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining,
sports biotech, water, renewable energy and more. Investor Idea’s original
branded content includes the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move
podcast and column, Cleantech
and Climate Change , Exploring
Mining
the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investing involves risk and possible losses. This
site is currently compensated for news publication and distribution, social
media and marketing, content creation and more. Disclosure is posted for each
compensated news release, content published /created if required but otherwise
the news was not compensated for and was published for the sole interest of our
readers and followers. Contact management and IR of each company directly
regarding specific questions. Disclosure: this news article featuring
CSUI is a paid for news release on Investorideas.com – third party (two
thousand) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each country. Please
read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Follow
us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile
App
for iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact
Investorideas.com
800-665-0411
Get
more Cannabis Stock Investor Ideas - news,
articles, podcasts and stock
directories
Buy a cannabis guest post on Investorideas.com
Subscribe to:
Posts (Atom)
-
Investorideas.com - Cannabis Stock News: TransCanna (CSE: TCAN) Product Ranks in Leafly's Top Cannabis Strains List
-
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ...